Report Thumbnail
Product Code LP091490748BWX
Published Date 2024/3/29
English80 PagesGlobal

Global Biosynthesis of Cannabinoids Market Growth (Status and Outlook) 2024-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP091490748BWX◆The Mar 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/3/29
English 80 PagesGlobal

Global Biosynthesis of Cannabinoids Market Growth (Status and Outlook) 2024-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

According to this study, the global Biosynthesis of Cannabinoids market size will reach US$ million by 2030._x000D_ Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses._x000D_ This report presents a comprehensive overview, market shares, and growth opportunities of Biosynthesis of Cannabinoids market by product type, application, key players and key regions and countries._x000D_ Segmentation by product type:_x000D_ THC_x000D_ CBD_x000D_ Others_x000D_ Segmentation by Application: _x000D_ Food Industry_x000D_ Medical Industry_x000D_ Others_x000D_ This report also splits the market by region:_x000D_ United States_x000D_ China_x000D_ Europe_x000D_ Other regions:_x000D_ Japan_x000D_ South Korea_x000D_ Southeast Asia_x000D_ Rest of world_x000D_ The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:_x000D_ Anandia Laboratories_x000D_ Gingko Bioworks_x000D_ Hyasynth Bio_x000D_ InMed Pharmaceuticals_x000D_ Librede_x000D_ Renew Biopharma_x000D_ Cronos Group_x000D_ Organigram_x000D_ Teewinot Life Sciences_x000D_ ICC International Cannabis Corp._x000D_ Biotii Technologies Corp._x000D_ Bristol-Myers Squibb_x000D_ Biogen Inc._x000D_ GW Pharmaceuticals_x000D_

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Biosynthesis of Cannabinoids Market Size 2024-2030
      • 2.1.2 Biosynthesis of Cannabinoids Market Size CAGR by Region
    • 2.2 Biosynthesis of Cannabinoids Segment by Type
      • 2.2.1 THC
      • 2.2.2 CBD
      • 2.2.3 Others
    • 2.3 Biosynthesis of Cannabinoids Market Size by Type
      • 2.3.1 Global Biosynthesis of Cannabinoids Market Size Market Share by Type (2024-2030)
      • 2.3.2 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (2024-2030)
    • 2.4 Biosynthesis of Cannabinoids Segment by Application
      • 2.4.1 Food Industry
      • 2.4.2 Medical Industry
      • 2.4.3 Others
    • 2.5 Biosynthesis of Cannabinoids Market Size by Application
      • 2.5.1 Global Biosynthesis of Cannabinoids Market Size Market Share by Application (2024-2030)
      • 2.5.2 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Application (2024-2030)
  • 3 Biosynthesis of Cannabinoids Key Players

    • 3.1 Date of Key Players Enter into Biosynthesis of Cannabinoids
    • 3.2 Key Players Biosynthesis of Cannabinoids Product Offered
    • 3.3 Key Players Biosynthesis of Cannabinoids Funding/Investment Analysis
    • 3.4 Funding/Investment
      • 3.4.1 Funding/Investment by Regions
      • 3.4.2 Funding/Investment by End-Industry
    • 3.5 Key Players Biosynthesis of Cannabinoids Valuation & Market Capitalization
    • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
    • 3.7 Market Ranking
    • 3.8 New Product/Technology Launches
    • 3.9 Partnerships, Agreements, and Collaborations
    • 3.10 Mergers and Acquisitions
  • 4 Biosynthesis of Cannabinoids by Regions

    • 4.1 Biosynthesis of Cannabinoids Market Size by Regions (2024-2030)
    • 4.2 United States Biosynthesis of Cannabinoids Market Size Growth (2024-2030)
    • 4.3 China Biosynthesis of Cannabinoids Market Size Growth (2024-2030)
    • 4.4 Europe Biosynthesis of Cannabinoids Market Size Growth (2024-2030)
    • 4.5 Rest of World Biosynthesis of Cannabinoids Market Size Growth (2024-2030)
  • 5 United States

    • 5.1 United States Biosynthesis of Cannabinoids Market Size by Type (2024-2030)
    • 5.2 United States Biosynthesis of Cannabinoids Market Size by Application (2024-2030)
  • 6 Europe

    • 6.1 Europe Biosynthesis of Cannabinoids Market Size by Type (2024-2030)
    • 6.2 Europe Biosynthesis of Cannabinoids Market Size by Application (2024-2030)
  • 7 China

    • 7.1 China Biosynthesis of Cannabinoids Market Size by Type (2024-2030)
    • 7.2 China Biosynthesis of Cannabinoids Market Size by Application (2024-2030)
  • 8 Rest of World

    • 8.1 Rest of World Biosynthesis of Cannabinoids Market Size by Type (2024-2030)
    • 8.2 Rest of World Biosynthesis of Cannabinoids Market Size by Application (2024-2030)
    • 8.3 Japan
    • 8.4 South Korea
    • 8.5 Southeast Asia
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Key Investors in Biosynthesis of Cannabinoids

    • 10.1 Company A
      • 10.1.1 Company A Company Details
      • 10.1.2 Company Description
      • 10.1.3 Companies Invested by Company A
      • 10.1.4 Company A Key Development and Market Layout
    • 10.2 Company B
      • 10.2.1 Company B Company Details
      • 10.2.2 Company Description
      • 10.2.3 Companies Invested by Company B
      • 10.2.4 Company B Key Development and Market Layout
    • 10.3 Company C
      • 10.3.1 Company C Company Details
      • 10.3.2 Company Description
      • 10.3.3 Companies Invested by Company C
      • 10.3.4 Company C Key Development and Market Layout
    • 10.4 Company D
    • 10.5 ……
  • 11 Key Players Analysis

    • 11.1 Anandia Laboratories
      • 11.1.1 Anandia Laboratories Company Details
      • 11.1.2 Anandia Laboratories Biosynthesis of Cannabinoids Product Offered
      • 11.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.1.4 Anandia Laboratories Main Business Overview
      • 11.1.5 Anandia Laboratories News
    • 11.2 Gingko Bioworks
      • 11.2.1 Gingko Bioworks Company Details
      • 11.2.2 Gingko Bioworks Biosynthesis of Cannabinoids Product Offered
      • 11.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.2.4 Gingko Bioworks Main Business Overview
      • 11.2.5 Gingko Bioworks News
    • 11.3 Hyasynth Bio
      • 11.3.1 Hyasynth Bio Company Details
      • 11.3.2 Hyasynth Bio Biosynthesis of Cannabinoids Product Offered
      • 11.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.3.4 Hyasynth Bio Main Business Overview
      • 11.3.5 Hyasynth Bio News
    • 11.4 InMed Pharmaceuticals
      • 11.4.1 InMed Pharmaceuticals Company Details
      • 11.4.2 InMed Pharmaceuticals Biosynthesis of Cannabinoids Product Offered
      • 11.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.4.4 InMed Pharmaceuticals Main Business Overview
      • 11.4.5 InMed Pharmaceuticals News
    • 11.5 Librede
      • 11.5.1 Librede Company Details
      • 11.5.2 Librede Biosynthesis of Cannabinoids Product Offered
      • 11.5.3 Librede Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.5.4 Librede Main Business Overview
      • 11.5.5 Librede News
    • 11.6 Renew Biopharma
      • 11.6.1 Renew Biopharma Company Details
      • 11.6.2 Renew Biopharma Biosynthesis of Cannabinoids Product Offered
      • 11.6.3 Renew Biopharma Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.6.4 Renew Biopharma Main Business Overview
      • 11.6.5 Renew Biopharma News
    • 11.7 Cronos Group
      • 11.7.1 Cronos Group Company Details
      • 11.7.2 Cronos Group Biosynthesis of Cannabinoids Product Offered
      • 11.7.3 Cronos Group Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.7.4 Cronos Group Main Business Overview
      • 11.7.5 Cronos Group News
    • 11.8 Organigram
      • 11.8.1 Organigram Company Details
      • 11.8.2 Organigram Biosynthesis of Cannabinoids Product Offered
      • 11.8.3 Organigram Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.8.4 Organigram Main Business Overview
      • 11.8.5 Organigram News
    • 11.9 Teewinot Life Sciences
      • 11.9.1 Teewinot Life Sciences Company Details
      • 11.9.2 Teewinot Life Sciences Biosynthesis of Cannabinoids Product Offered
      • 11.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.9.4 Teewinot Life Sciences Main Business Overview
      • 11.9.5 Teewinot Life Sciences News
    • 11.10 ICC International Cannabis Corp
      • 11.10.1 ICC International Cannabis Corp. Company Details
      • 11.10.2 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product Offered
      • 11.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Market Size (2024 VS 2030)
      • 11.10.4 ICC International Cannabis Corp. Main Business Overview
      • 11.10.5 ICC International Cannabis Corp. News
    • 11.11 Biotii Technologies Corp
    • 11.12 Bristol-Myers Squibb
    • 11.13 Biogen Inc
    • 11.14 GW Pharmaceuticals
  • 12 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.